|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/25/14 Bone Biologics Corp 8-K:1,2,3,5 9/19/14 79:9M M2 Compliance/FA |
Document/Exhibit Description Pages Size
1: 8-K Current Report HTML 980K
2: EX-2.1 Plan of Acquisition, Reorganization, Arrangement, HTML 433K
Liquidation or Succession
3: EX-2.2 Plan of Acquisition, Reorganization, Arrangement, HTML 47K
Liquidation or Succession
4: EX-3.1I Articles of Incorporation/Organization or Bylaws HTML 28K
5: EX-3.1II Articles of Incorporation/Organization or Bylaws HTML 64K
6: EX-4.1 Instrument Defining the Rights of Security Holders HTML 66K
15: EX-4.10 Instrument Defining the Rights of Security Holders HTML 84K
16: EX-4.11 Instrument Defining the Rights of Security Holders HTML 64K
17: EX-4.12 Instrument Defining the Rights of Security Holders HTML 85K
18: EX-4.13 Instrument Defining the Rights of Security Holders HTML 76K
19: EX-4.14 Instrument Defining the Rights of Security Holders HTML 75K
20: EX-4.15 Instrument Defining the Rights of Security Holders HTML 73K
21: EX-4.16 Instrument Defining the Rights of Security Holders HTML 73K
22: EX-4.17 Instrument Defining the Rights of Security Holders HTML 70K
23: EX-4.18 Instrument Defining the Rights of Security Holders HTML 74K
24: EX-4.19 Instrument Defining the Rights of Security Holders HTML 155K
7: EX-4.2 Instrument Defining the Rights of Security Holders HTML 67K
25: EX-4.20 Instrument Defining the Rights of Security Holders HTML 85K
26: EX-4.21 Instrument Defining the Rights of Security Holders HTML 57K
27: EX-4.22 Instrument Defining the Rights of Security Holders HTML 136K
28: EX-4.23 Instrument Defining the Rights of Security Holders HTML 32K
29: EX-4.24 Instrument Defining the Rights of Security Holders HTML 38K
30: EX-4.25 Instrument Defining the Rights of Security Holders HTML 30K
8: EX-4.3 Instrument Defining the Rights of Security Holders HTML 68K
9: EX-4.4 Instrument Defining the Rights of Security Holders HTML 36K
10: EX-4.5 Instrument Defining the Rights of Security Holders HTML 70K
11: EX-4.6 Instrument Defining the Rights of Security Holders HTML 86K
12: EX-4.7 Instrument Defining the Rights of Security Holders HTML 82K
13: EX-4.8 Instrument Defining the Rights of Security Holders HTML 91K
14: EX-4.9 Instrument Defining the Rights of Security Holders HTML 84K
31: EX-10.1 Material Contract HTML 39K
40: EX-10.10 Material Contract HTML 58K
41: EX-10.11 Material Contract HTML 71K
42: EX-10.12 Material Contract HTML 57K
43: EX-10.13 Material Contract HTML 66K
44: EX-10.14 Material Contract HTML 236K
45: EX-10.15 Material Contract HTML 88K
46: EX-10.16 Material Contract HTML 215K
47: EX-10.17 Material Contract HTML 91K
48: EX-10.18 Material Contract HTML 90K
32: EX-10.2 Material Contract HTML 161K
33: EX-10.3 Material Contract HTML 48K
34: EX-10.4 Material Contract HTML 44K
35: EX-10.5 Material Contract HTML 44K
36: EX-10.6 Material Contract HTML 47K
37: EX-10.7 Material Contract HTML 47K
38: EX-10.8 Material Contract HTML 45K
39: EX-10.9 Material Contract HTML 57K
49: EX-21.1 Subsidiaries List HTML 20K
66: R1 Document and Entity Information HTML 33K
61: R2 Balance Sheets (Unaudited) HTML 166K
64: R3 Balance Sheets (Unaudited) (Parenthetical) HTML 47K
68: R4 Statement of Operations (Unaudited) HTML 77K
76: R5 Statements of Stockholders' Deficit HTML 90K
62: R6 Statements of Stockholders' Deficit HTML 22K
(Parenthetical)
63: R7 Condensed Statements of Cash Flows (Unaudited) HTML 109K
60: R8 Basis of Presentation HTML 29K
58: R9 The Company HTML 37K
77: R10 Summary of Significant Accounting Policies HTML 49K
70: R11 Accrued Expenses HTML 38K
69: R12 Commitments and Contingencies HTML 60K
73: R13 Notes Payable to Related Party HTML 85K
74: R14 Stockholders' Equity HTML 115K
72: R15 Income Taxes HTML 55K
75: R16 Related Party Transactions HTML 32K
65: R17 Subsequent Events HTML 28K
67: R18 Transaction HTML 37K
71: R19 Proforma Adjustments - Consolidated Statement of HTML 47K
Financial Position
79: R20 Proforma Adjustment - Statement of Operations HTML 29K
78: XML IDEA XML File -- Filing Summary XML 63K
56: EXCEL IDEA Workbook of Financial Reports XLSX 113K
59: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 479K
50: EX-101.INS XBRL Instance -- boneb-20140630 XML 1.02M
52: EX-101.CAL XBRL Calculations -- boneb-20140630_cal XML 93K
53: EX-101.DEF XBRL Definitions -- boneb-20140630_def XML 304K
54: EX-101.LAB XBRL Labels -- boneb-20140630_lab XML 353K
55: EX-101.PRE XBRL Presentations -- boneb-20140630_pre XML 307K
51: EX-101.SCH XBRL Schema -- boneb-20140630 XSD 73K
57: ZIP XBRL Zipped Folder -- 0001493152-14-003110-xbrl Zip 77K
CERTIFIED TRUE COPY
| BANK OF AMERICA – CONFIDENTIAL | PAGE: 1 |
IRREVOCABLE STANDBY LETTER OF CREDIT NUMBER: 68105133
ISSUING BANK BANK OF AMERICA, N.A. ONE FLEET WAY PA6-580-02-30 | |
BENEFICIARY AFH HOLDING & ADVISORY, LLC AMIR F HESHMATPOUR CHAIRMAN & MANAGING DIRECTOR 9595 WILSHIRE BLVD SUITE 700 |
APPLICANT MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. 125 MAY STREET |
AMOUNT
NOT EXCEEDING USD 340,000.00
NOT EXCEEDING THREE HUNDRED FORTY THOUSAND AND 00/100’S US DOLLARS
EXPIRATION
GENTLEMEN:
WE HEREBY OPEN OUR IRREVOCABLE STANDBY LETTER OF CREDIT NUMBER 68105133 IN YOUR FAVOR.
THIS CREDIT IS AVAILABLE WITH BANK OF AMERICA BY PAYMENT AGAINST PRESENTATION OF BENEFICIARY’S DRAFT(S) AT SIGHT DRAWN ON BANK OF AMERICA N.A.
DRAFT(S) MUST BE ACCOMPANIED BY:
1. THE ORIGINAL LETTER OF CREDIT AND ALL AMENDMENTS, IF ANY.
2. AN AFFIDAVIT SIGNED BY AFH HOLDING AND ADVISORY LLC, CERTIFYING ONE OF THE FOLLOWING:
QUOTE
A. BONE BIOLOGICS HAS FAILED TO RECEIVE EXTERNAL FUNDING TO EXTINGUISH THE FULL AMOUNT OF $340,000 OR A PORTION THEREOF STILL OWED UNDER THE PURCHASE AGREEMENT TO ACQUIRE AFH ACQUISITION X, OR HAS NOT PAID AMOUNTS DUE AND OUTSTANDING. AS OF THE DATE OF THIS DRAWING SUCH PAYMENT HAS NOT BEEN RECEIVED, AND THEREFORE WE DRAW IN THE AMOUNT OF $___________ OWED BY BONE BILOGICS.
C:
CERTIFIED TRUE COPY
| BANK OF AMERICA – CONFIDENTIAL | PAGE: 2 |
UNQUOTE
QUOTE
B. BONE BIOLOGICS HAS RECEIVED EXTERNAL FUNDING TO EXTINGUISH THE FULL AMOUNT OF $340,000 OR A PORTION THEREOF STILL OWED UNDER THE PURCHASE AGREEMENT TO ACQUIRE AFH ACQUISITION X, BUT HAS NOT PAID AMOUNTS DUE AND OUTSTANDING. AS OF THE DATE OF THIS DRAWING SUCH PAYMENT HAS NOT BEEN RECEIVED, AND THEREFORE WE DRAW IN THE AMOUNT OF $ OWED BY BONE BILOGICS.
UNQUOTE
PARTIAL DRAWINGS AND MULTIPLE DRAWINGS ARE ALLOWED.
DRAFT(S) MUST STATE “DRAWN UNDER BANK OF AMERICA N.A., STANDBY LETTER OF CREDIT NUMBER 68105133 DATED JULY 22, 2015.”
DRAFT(S) AND DOCUMENTS SHALL BE PRESENTED AT OUR OFFICES AT BANK OF AMERICA, N.A. ONE FLEET WAY, PA6-580 - 02-30, SCRANTON, PA 18507-1999, ATTN: GLOBAL TRADE OPERATIONS, STANDBY UNIT.
THIS LETTER OF CREDIT IS TRANSFERABLE IN FULL AND NOT IN PART. ANY TRANSFER MADE HEREUNDER MUST CONFORM STRICTLY TO THE TERMS HEREOF AND TO THE CONDITIONS OF RULE 6 OF THE INTERNATIONAL STANDBY PRACTICES (ISP98) FIXED BY THE INTERNATIONAL CHAMBER OF COMMERCE, PUBLICATION NO. 590. SHOULD YOU WISH TO EFFECT A TRANSFER UNDER THIS CREDIT, SUCH TRANSFER WILL BE SUBJECT TO THE RETURN TO US OF THE ORIGINAL CREDIT INSTRUMENT, ACCOMPANIED BY OUR FORM OF TRANSFER, PROPERLY COMPLETED AND SIGNED BY AN AUTHORIZED SIGNATORY OF YOUR FIRM, BEARING YOUR BANKERS STAMP AND SIGNATURE AUTHENTICATION AND PAYMENT OF OUR TRANSFER FEE. SUCH TRANSFER FORM TRANSFER FORM IS AVAILABLE UPON REQUEST.
COMMUNICATIONS WITH RESPECT TO THIS LETTER OF CREDIT SHALL BE IN WRITING AND SHALL BE ADDRESSED TO US AT ONE FLEET WAY, PA6-580 - 02 - 30, SCRANTON, PA 18507-1999, ATTN: GLOBAL TRADE OPERATIONS, STANDBY UNIT, PHONE: 1-800-370-7519, SPECIFICALLY REFERRING TO THE NUMBER OF THIS LETTER OF CREDIT.
EXCEPT AS OTHERWISE EXPRESSLY STATED HEREIN, THIS CREDIT IS ISSUED SUBJECT TO THE INTERNATIONAL STANDBY PRACTICES (ISP98), INTERNATIONAL CHAMBER OF COMMERCE PUBLICATION NO. 590.
IF YOU REQUIRE ANY ASSISTANCE OR HAVE ANY QUESTIONS REGARDING THIS TRANSACTION, PLEASE CALL 800-370-7519 OPT 1 .
C:
CERTIFIED TRUE COPY
| BANK OF AMERICA – CONFIDENTIAL | PAGE: 3 |
THIS IS AN INTEGRAL PART OF LETTER OF CREDIT NUMBER: 68105133
AUTHORIZED SIGNATURE
THIS DOCUMENT CONSISTS OF 3 PAGE(S).
C:
BANK OF AMERICA – CONFIDENTIAL |
PAGE: 1 |
DATE: JULY 28, 2014 | |
AMENDMENT TO IRREVOCABLE STANDBY LETTER OF CREDIT NUMBER: 68105133 | |
AMENDMENT NUMBER 1 |
ISSUING BANK BANK OF AMERICA, N.A. ONE FLEET WAY PA6-580-02-30 | |
BENEFICIARY AFH HOLDING & ADVISORY, LLC AMIR F HESHMATPOUR CHAIRMAN & MANAGING DIRECTOR 10830 MASSACHUSETTS AVE |
APPLICANT MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. 125 MAY STREET |
PENTHOUSE SUITE
LOS ANGELES, CA 90 024
THIS AMENDMENT IS TO BE CONSIDERED AN INTEGRAL PART OF THE ABOVE CRED: AND MUST BE ATTACHED THERETO.
THE ABOVE MENTIONED CREDIT IS AMENDED AS FOLLOWS:
THE BENEFICIARY HAS BEEN AMENDED TO:
AFH HOLDING & ADVISORY, LLC
AMIR F HESHMATPOUR
CHAIRMAN & MANAGING DIRECTOR
10830 MASSACHUSETTS AVE
PENTHOUSE SUITE
ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED.
IF YOU REQUIRE ANY ASSISTANCE OR HAVE ANY QUESTIONS REGARDING THIS AMENDMENT, PLEASE CALL 800-370-7519 OPT 1 .
C:
BANK OF AMERICA – CONFIDENTIAL |
PAGE: 2 |
AUTHORIZED SIGNATURE
THIS DOCUMENT CONSISTS OF 2 PAGE(S).
C:
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 7/25/15 | ||||
| 7/22/15 | ||||
| Filed on: | 9/25/14 | |||
| For Period end: | 9/19/14 | 3, 4 | ||
| 7/28/14 | 8-K | |||
| 7/25/14 | ||||
| List all Filings | ||||